The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Anna R GiulianoManuel Quiterio

Abstract

Male sexual behavior influences the rates of cervical dysplasia and invasive cervical cancer, as well as male human papillomavirus (HPV) infection and disease. Unfortunately, little is known regarding male HPV type distribution by age and across countries. In samples combined from the coronal sulcus, glans penis, shaft, and scrotum of 1,160 men from Brazil, Mexico, and the United States, overall HPV prevalence was 65.2%, with 12.0% oncogenic types only, 20.7% nononcogenic types only, 17.8% both oncogenic and nononcogenic, and 14.7% unclassified infections. Multiple HPV types were detected in 25.7% of study participants. HPV prevalence was higher in Brazil (72.3%) than in the United States (61.3%) and Mexico (61.9%). HPV16 (6.5%), HPV51 (5.3%), and HPV59 (5.3%) were the most commonly detected oncogenic infections, and HPV84 (7.7%), HPV62 (7.3%), and HPV6 (6.6%) were the most commonly detected nononcogenic infections. Overall HPV prevalence was not associated with age. However, significant associations with age were observed when specific categories of HPV, nononcogenic, and unclassified HPV infections were considered. Studies of HPV type distribution among a broad age range of men from multiple countries is needed to fill the in...Continue Reading

References

Feb 1, 1986·American Journal of Epidemiology·M V ZunzuneguiJ Charlet
Apr 15, 1996·American Journal of Epidemiology·D B ThomasG Riotton
Aug 7, 1996·Journal of the National Cancer Institute·F X BoschK V Shah
Nov 14, 1997·The New England Journal of Medicine·K V Shah
Jan 5, 2000·Journal of Clinical Microbiology·P E GravittR J Apple
Mar 5, 2002·British Journal of Cancer·S FranceschiN Muñoz
Apr 12, 2002·The New England Journal of Medicine·Xavier CastellsaguéUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Feb 10, 2004·The Journal of Infectious Diseases·Bethany A WeaverLaura A Koutsky
Apr 16, 2005·The Lancet Oncology·Vincent CoglianoUNKNOWN WHO International Agency for Research on Cancer
Jul 21, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Martín LajousEduardo Lazcano-Ponce
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maaike C G BleekerChris J L M Meijer
Feb 4, 2006·Journal of Clinical Microbiology·Brenda Y HernandezL Ning
Feb 14, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R L RombaldiS Paesi
May 19, 2006·International Journal of Cancer. Journal International Du Cancer·Salvatore VaccarellaSilvia Franceschi
Sep 23, 2006·The Journal of Infectious Diseases·Eileen F DunneAnna R Giuliano
Jun 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Carrie M NielsonAnna R Giuliano
Feb 19, 2008·Journal of Virological Methods·Roberto FloresAnna R Giuliano
Apr 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anna R Giuliano, Daniel Salmon

❮ Previous
Next ❯

Citations

Mar 3, 2011·Current Infectious Disease Reports·Luis F Barroso, Timothy Wilkin
Feb 4, 2011·The New England Journal of Medicine·Anna R GiulianoDalya Guris
Dec 15, 2010·The Journal of Infectious Diseases·Eftyhia VardasDalya Guris
Sep 13, 2011·The Journal of Infectious Diseases·Salvatore VaccarellaAnna R Giuliano
Nov 8, 2011·The Journal of Infectious Diseases·Anne F RositchJennifer S Smith
Mar 8, 2012·The Journal of Infectious Diseases·Kimberly K ReppUNKNOWN HIM study
Apr 28, 2012·The Journal of Infectious Diseases·Alan G NyitrayAnna R Giuliano
Jun 20, 2012·The Journal of Infectious Diseases·Anne F RositchJennifer S Smith
May 7, 2013·The Journal of Infectious Diseases·Christine M Pierce CampbellAnna R Giuliano
Aug 26, 2009·Sexually Transmitted Diseases·Ann N BurchellEduardo L Franco
Feb 2, 2010·Sexually Transmitted Diseases·Paul L ReiterJennifer S Smith
Dec 21, 2011·Sexually Transmitted Diseases·Henrike J VriendUNKNOWN Municipal Health Services
Aug 24, 2013·Sexually Transmitted Diseases·Tina Bech OlesenSusanne Krüger Kjaer
Mar 12, 2009·Current Opinion in Infectious Diseases·Alexander Kreuter, Ulrike Wieland
Dec 14, 2011·Clinical and Vaccine Immunology : CVI·Richard J HillmanElizabeth I O Garner
Jun 12, 2012·Sexually Transmitted Infections·Eva HamsikovaRuth Tachezy
Dec 15, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Aimee R KreimerAnna R Giuliano
Sep 7, 2011·Cancer Prevention Research·Aimée R Kreimer, Anil K Chaturvedi
Feb 9, 2013·BMC Public Health·Andrea LenziCarla Maria Zotti
Jul 13, 2013·BMC Public Health·Piergiorgio CrosignaniGian Vincenzo Zuccotti
Nov 6, 2010·BMC Research Notes·Gitte Lee Mortensen, Helle K Larsen
Feb 2, 2013·PloS One·Marta Elena Álvarez-ArgüellesMaría de Oña
Jul 4, 2009·World Journal of Gastroenterology : WJG·Roberto Herrera-GoepfertMauricio Becker-D'Acosta
Oct 3, 2012·American Journal of Health Behavior·Ellen M DaleyAnna R Giuliano
Nov 21, 2013·The Journal of Infectious Diseases·Alan G NyitrayAnna R Giuliano
Sep 27, 2013·Journal of Community Health·Angélica Dolores Ramírez-Rios, William Bonnez
Nov 23, 2013·The Journal of Infectious Diseases·Ross D Cranston
Jan 28, 2014·Oral Oncology·Kristen B PytyniaErich M Sturgis
Apr 1, 2014·The Journal of Infectious Diseases·Ann N BurchellEduardo L Franco
Jul 4, 2012·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Eric M GendenAlfio Ferlito
Dec 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeanne M Marrazzo, Willard Cates
Oct 1, 2014·Expert Review of Vaccines·Sandra D IsideanEduardo L Franco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.